You have 9 free searches left this month | for more free features.

T-cell vaccine

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostatic Tumors, Prostate Cancer Trial run by the NCI (Autologus elutriated monocyte vaccine, Multi-epitope (ME) T-cell

Terminated
  • Prostatic Neoplasms
  • Prostate Cancer
  • Autologus elutriated monocyte placebo vaccine
  • Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2022

Carcinoma, Melanoma, Bladder Cancer Trial in Chengdu (Tumor antigen-sensitized DC vaccine and their sensitized T cells

Not yet recruiting
  • Carcinoma
  • +3 more
  • Tumor antigen-sensitized DC vaccine and their sensitized T cells subcutaneous administration
  • Chengdu, Sichuan, China
    West China Hospital
Feb 10, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Prostate Cancer, Non Small Cell Lung Cancer, Ovarian Cancer Trial in London, Oxford (OVM-200)

Recruiting
  • Prostate Cancer
  • +2 more
  • OVM-200
  • London, United Kingdom
  • +2 more
Apr 26, 2022

COVID-19 Infection, Hematopoietic and Lymphoid System Tumor, Leukemia Trial in Duarte (COVID-19 Vaccine, Diagnostic Laboratory

Recruiting
  • COVID-19 Infection
  • +4 more
  • COVID-19 Vaccine
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 2, 2021

COVID-19 Respiratory Infection, Influenza Trial in Tucson (COVID-19 Vaccine)

Recruiting
  • COVID-19 Respiratory Infection
  • Influenza
  • COVID-19 Vaccine
  • Tucson, Arizona
    University of Arizona
Sep 28, 2021

COVID-19 Vaccine Responses in PIDD Subjects

Recruiting
  • X-linked Agammaglobulinemia
  • +6 more
    • Saint Petersburg, Florida
    • +2 more
    Apr 7, 2022

    Malignant Solid Tumour, Breast Cancer, Malignant Tumor of Colon Trial in Columbus (HER-2 vaccine, Extension HER-2 vaccine trial

    Recruiting
    • Malignant Solid Tumour
    • +4 more
    • HER-2 vaccine
    • Extension HER-2 vaccine trial at OBD
    • Columbus, Ohio
      Ohio State University Medical Center
    Oct 26, 2021

    Influenza Trial in Rochester (FluBlok, Fluzone, FluCelVax)

    Completed
    • Influenza
    • FluBlok
    • +3 more
    • Rochester, New York
      University of Rochester Medical Center, Vaccine Research Unit Ro
    Nov 1, 2021

    COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in

    Not yet recruiting
    • Follicular Lymphoma
    • Cellular immunity vs SARS-CoV-2
    • +6 more
    • Alessandria, IT, Italy
    • +13 more
    Oct 10, 2023

    Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)

    Active, not recruiting
    • Medulloblastoma
    • Neuroectodermal Tumor
    • TTRNA-xALT
    • TTRNA-DCs
    • Los Angeles, California
    • +2 more
    Jan 7, 2022

    Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)

    Not yet recruiting
    • Diffuse Hemispheric Glioma, H3 G34-Mutant
    • Dendritic Cell Tumor Peptide Vaccine
    • +6 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jul 13, 2022

    Triple Negative Breast Cancer Trial in El Segundo (drug, biological, procedure)

    Active, not recruiting
    • Triple Negative Breast Cancer
    • Aldoxorubicin HCl
    • +17 more
    • El Segundo, California
      Chan Soon-Shiong Institute for Medicine
    Mar 28, 2022

    Immune Responses to COVID-19 Vaccination in Lymphoma Patients

    Active, not recruiting
    • Classical Hodgkin Lymphoma
    • +12 more
      • Bedford, Bedfordshire, United Kingdom
      • +8 more
      Feb 22, 2022

      Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

      Not yet recruiting
      • Esophageal Cancer
      • +3 more
      • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
      • Edegem, Belgium
        Antwerp University Hospital
      Jul 19, 2023

      Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,

      Recruiting
      • Breast Ductal Carcinoma In Situ
      • Granulocyte-Macrophage Colony-Stimulating Factor
      • +2 more
      • Jacksonville, Florida
      • +1 more
      Dec 10, 2021

      Metastatic Malignant Melanoma Trial in Oslo (Dendritic cells - transfected with hTERT-, survivin- and tumor cell derived mRNA +

      Terminated
      • Metastatic Malignant Melanoma
      • Dendritic cells - transfected with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion
      • Temozolomide
      • Oslo, Montebello, Norway
        The Norwegian Radium Hospital, Department of Clinical Cancer Res
      Feb 23, 2021

      A T Cell-based HIV Vaccine

      Recruiting
      • HIV
      • HIV positive subjects
      • Non-infected control subjects
      • Gainesville, Florida
      • +1 more
      Feb 11, 2021

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +9 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +7 more
      • Duarte, California
      • +1 more
      Sep 22, 2023

      Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • COVID-19 Infection
      • Biospecimen Collection
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jan 3, 2023

      COVID-19 Pandemic, COVID-19 Vaccines Trial in Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg,

      Recruiting
      • COVID-19 Pandemic
      • COVID-19 Vaccines
      • Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
      • CoronaVac Biofarma COVID-1 9 Vaccine 3 µg
      • Surabaya, East Java, Indonesia
        Dr. Soetomo General Hospital
      Jun 21, 2023

      Herpes Zoster Trial in Makati City (REC610, Shingrix)

      Recruiting
      • Herpes Zoster
      • REC610
      • Shingrix
      • Makati City, Metro Manila, Philippines
        Pharma Peak Research Philippines,Inc.
      Mar 13, 2023

      Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

      Recruiting
      • Extranodal NK T Cell Lymphoma
      • NK-Cell Leukemia
      • Anti-CD56 CAR T
      • Xuzhou, Jiangsu, China
        The Affiliated Hospital of Xuzhou Medical University
      Jul 10, 2023

      T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • Hangzhou, Zhejiang, China
        The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
      Aug 7, 2023